AUCATZYL Trademark

Trademark Overview


On Thursday, April 27, 2023, a trademark application was filed for AUCATZYL with the United States Patent and Trademark Office. The USPTO has given the AUCATZYL trademark a serial number of 79370753. The federal status of this trademark filing is REGISTERED as of Tuesday, July 9, 2024. This trademark is owned by Autolus Limited. The AUCATZYL trademark is filed in the Pharmaceutical Products category with the following description:

Medical and veterinary preparations for therapeutic purposes for the treatment of cancer, genetic conditions, immune response disorders, autoimmune diseases and infectious diseases; medical preparations for cell therapy for the treatment of cancer, genetic conditions, immune response disorders, autoimmune diseases and infectious diseases; medical preparations for gene therapy for the treatment of cancer, genetic conditions, immune response disorders, autoimmune diseases and infectious diseases; medical preparations for cancer therapies for the treatment of cancer, genetic conditions, immune response disorders, autoimmune diseases and infectious diseases; cells for medical or clinical use, namely cells featuring chimeric antigen receptors (CAR) and therapeutic preparations thereof for the treatment of cancer, genetic conditions, immune response disorders, autoimmune diseases and infectious diseases; antibodies for medical purposes for the treatment of cancer, genetic conditions, immune ...
aucatzyl

General Information


Serial Number79370753
Word MarkAUCATZYL
Filing DateThursday, April 27, 2023
Status700 - REGISTERED
Status DateTuesday, July 9, 2024
Registration Number7435621
Registration DateTuesday, July 9, 2024
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, April 23, 2024

Trademark Statements


Goods and ServicesMedical and veterinary preparations for therapeutic purposes for the treatment of cancer, genetic conditions, immune response disorders, autoimmune diseases and infectious diseases; medical preparations for cell therapy for the treatment of cancer, genetic conditions, immune response disorders, autoimmune diseases and infectious diseases; medical preparations for gene therapy for the treatment of cancer, genetic conditions, immune response disorders, autoimmune diseases and infectious diseases; medical preparations for cancer therapies for the treatment of cancer, genetic conditions, immune response disorders, autoimmune diseases and infectious diseases; cells for medical or clinical use, namely cells featuring chimeric antigen receptors (CAR) and therapeutic preparations thereof for the treatment of cancer, genetic conditions, immune response disorders, autoimmune diseases and infectious diseases; antibodies for medical purposes for the treatment of cancer, genetic conditions, immune response disorders, autoimmune diseases and infectious diseases; preparations for genetically modifying human or animal cells for medical purposes, including viral vectors, namely, culture media for cultivating and augmentation of human and animal cells; preparations of blood extracted from humans or animals which have been adapted for therapeutic purposes; pharmaceutical preparations for use in the treatment of cancer; biological preparations for the treatment of cancer; pharmaceutical and biological preparations for immunotherapy, including T cell therapy; vaccines

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, June 2, 2023
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameAutolus Limited
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressGB

Party NameAutolus Limited
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressGB

Party NameAutolus Limited
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressGB

Trademark Events


Event DateEvent Description
Thursday, June 1, 2023SN ASSIGNED FOR SECT 66A APPL FROM IB
Friday, June 2, 2023NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, June 6, 2023APPLICATION FILING RECEIPT MAILED
Sunday, September 3, 2023CORRECTION TRANSACTION RECEIVED FROM IB
Wednesday, October 11, 2023CORRECTION FROM THE IB EXAMINED, NO ACTION IS NEEDED
Thursday, January 25, 2024ASSIGNED TO EXAMINER
Thursday, January 25, 2024NON-FINAL ACTION WRITTEN
Friday, January 26, 2024NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Tuesday, February 13, 2024REFUSAL PROCESSED BY MPU
Tuesday, February 13, 2024NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Thursday, February 29, 2024TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, February 29, 2024CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, March 1, 2024TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, March 4, 2024REFUSAL PROCESSED BY IB
Saturday, March 16, 2024APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, April 3, 2024NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, April 10, 2024NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Wednesday, April 10, 2024NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Tuesday, April 23, 2024PUBLISHED FOR OPPOSITION
Tuesday, April 23, 2024OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, April 30, 2024NOTIFICATION PROCESSED BY IB
Tuesday, July 9, 2024REGISTERED-PRINCIPAL REGISTER
Tuesday, July 9, 2024NOTICE OF REGISTRATION CONFIRMATION EMAILED